Mirum Pharmaceuticals Inc (MIRM)
43.22
+1.61
(+3.87%)
USD |
NASDAQ |
Nov 12, 15:21
Mirum Pharmaceuticals Revenue (TTM): 264.38M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 264.38M |
March 31, 2024 | 224.00M |
December 31, 2023 | 186.37M |
September 30, 2023 | 144.73M |
June 30, 2023 | 115.78M |
Date | Value |
---|---|
March 31, 2023 | 95.77M |
December 31, 2022 | 77.06M |
September 30, 2022 | 52.29M |
June 30, 2022 | 38.51M |
March 31, 2022 | 32.03M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
32.03M
Minimum
Mar 2022
264.38M
Maximum
Jun 2024
123.09M
Average
105.77M
Median
Revenue (TTM) Benchmarks
Arcutis Biotherapeutics Inc | 138.71M |
Cytokinetics Inc | 3.219M |
Amicus Therapeutics Inc | 493.67M |
MannKind Corp | 267.20M |
TG Therapeutics Inc | 264.79M |